↓ Skip to main content

Ziprasidone versus other atypical antipsychotics for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, October 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
157 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ziprasidone versus other atypical antipsychotics for schizophrenia
Published in
Cochrane database of systematic reviews, October 2009
DOI 10.1002/14651858.cd006627.pub2
Pubmed ID
Authors

Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Sandra Schwarz, Paranthaman Sethupathi Bhoopathi, Werner Kissling, Stefan Leucht

Abstract

In many countries of the industrialised world second generation ('atypical') antipsychotics have become the first line drug treatment for people with schizophrenia. The question as to whether, and if so how much, the effects of the various new generation antipsychotics differ is a matter of debate. In this review we examined how the efficacy and tolerability of ziprasidone differs from that of other second generation antipsychotics.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 151 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 14%
Student > Master 21 13%
Student > Bachelor 19 12%
Student > Ph. D. Student 13 8%
Student > Doctoral Student 12 8%
Other 35 22%
Unknown 35 22%
Readers by discipline Count As %
Medicine and Dentistry 61 39%
Psychology 15 10%
Nursing and Health Professions 14 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Agricultural and Biological Sciences 4 3%
Other 16 10%
Unknown 39 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2016.
All research outputs
#3,780,850
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#6,289
of 11,499 outputs
Outputs of similar age
#13,318
of 106,969 outputs
Outputs of similar age from Cochrane database of systematic reviews
#25
of 81 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 106,969 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.